Nanoform sets a new near-term business target for 2021
Insider information Nanoform Finland Plc January 4[th], 2021 at 08.10 a.m. Finnish time Nanoform sets a new near-term business target for 2021 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced a new near-term business target. In 2021 Nanoform targets “at least 12 new non-GMP[1] (pre-clinical) customer projects and at least one new GMP[ ](clinical) customer project”. The company reported 2 non-GMP customer projects in 2019 and 7 non-GMP customer projects in Q1-Q3/2020. Nanoform’s Q4/2020 report is due